Literature DB >> 27141423

HIV and viral protein effects on the blood brain barrier.

MaryPeace McRae1.   

Abstract

The blood brain barrier (BBB) plays a critical role in the normal physiology of the central nervous system (CNS) by regulating what crosses from the periphery into the brain. Damage to the BBB or alterations in transport systems may mediate the pathogenesis of many CNS diseases, including HIV-associated CNS dysfunction. HIV-1 infection can result in neuropathologic changes in about one half of infected individuals and also can result in damage to the BBB. HIV-1 and the HIV-1 viral proteins, Tat and gp120, cause alterations in the integrity and function of the BBB through both paracellular and transcellular mechanisms. The current review discusses HIV and viral protein-mediated injury to the BBB with a focus on the effects on tight junction proteins, barrier permeability, and drug efflux proteins.

Entities:  

Keywords:  HIV; P-glycoprotein; blood brain barrier; tight junctions; transporters

Mesh:

Substances:

Year:  2016        PMID: 27141423      PMCID: PMC4836474          DOI: 10.1080/21688370.2016.1143543

Source DB:  PubMed          Journal:  Tissue Barriers        ISSN: 2168-8362


  98 in total

1.  HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood-brain barrier.

Authors:  Kentaro Hayashi; Hong Pu; Ibolya E Andras; Sung Yong Eum; Atsushi Yamauchi; Bernhard Hennig; Michal Toborek
Journal:  J Cereb Blood Flow Metab       Date:  2005-12-14       Impact factor: 6.200

Review 2.  Mechanisms of the blood-brain barrier disruption in HIV-1 infection.

Authors:  Michal Toborek; Yong Woo Lee; Govinder Flora; Hong Pu; Ibolya E András; Edward Wylegala; Bernhard Hennig; Avindra Nath
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 3.  Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.

Authors:  David S Miller; Björn Bauer; Anika M S Hartz
Journal:  Pharmacol Rev       Date:  2008-06-17       Impact factor: 25.468

4.  Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues.

Authors:  L Hudson; J Liu; A Nath; M Jones; R Raghavan; O Narayan; D Male; I Everall
Journal:  J Neurovirol       Date:  2000-04       Impact factor: 2.643

5.  Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.

Authors:  E A Eugenin; R Gamss; C Buckner; D Buono; R S Klein; E E Schoenbaum; T M Calderon; J W Berman
Journal:  J Leukoc Biol       Date:  2006-01-13       Impact factor: 4.962

6.  Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism.

Authors:  Eliseo A Eugenin; Janice E Clements; M Christine Zink; Joan W Berman
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

7.  HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.

Authors:  Tulin Otamis Price; Nuran Ercal; Ryota Nakaoke; William A Banks
Journal:  Brain Res       Date:  2005-04-19       Impact factor: 3.252

8.  Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells.

Authors:  Shinichi Nakamuta; Hiroshi Endo; Youichiro Higashi; Aoi Kousaka; Hiroshi Yamada; Mihiro Yano; Hiroshi Kido
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

9.  Expression of HIV regulatory and structural mRNA in the central nervous system.

Authors:  C A Wiley; M Baldwin; C L Achim
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

10.  Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE).

Authors:  Yuri Persidsky; David Heilman; James Haorah; Marina Zelivyanskaya; Raisa Persidsky; Gregory A Weber; Hiroaki Shimokawa; Kozo Kaibuchi; Tsuneya Ikezu
Journal:  Blood       Date:  2006-02-14       Impact factor: 22.113

View more
  13 in total

Review 1.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Effects of docosahexaenoic acid on locomotor activity in ethanol-treated HIV-1 transgenic rats.

Authors:  Jianlin He; Wenfei Huang; Shizhong Zheng; Michael Vigorito; Sulie L Chang
Journal:  J Neurovirol       Date:  2017-12-19       Impact factor: 2.643

Review 3.  Signaling pathways regulating blood-tissue barriers - Lesson from the testis.

Authors:  Qing Wen; Elizabeth I Tang; Ying Gao; Tito T Jesus; Darren S Chu; Will M Lee; Chris K C Wong; Yi-Xun Liu; Xiang Xiao; Bruno Silvestrini; C Yan Cheng
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-04-25       Impact factor: 3.747

Review 4.  Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection.

Authors:  Lauren Killingsworth; Serena Spudich
Journal:  Semin Immunopathol       Date:  2022-07-26       Impact factor: 11.759

5.  Impact of Tobacco Smoke in HIV Progression: a Major Risk Factor for the Development of NeuroAIDS and Associated of CNS Disorders.

Authors:  Aditya Bhalerao; Luca Cucullo
Journal:  Z Gesundh Wiss       Date:  2019-03-09

Review 6.  Cerebral Vascular Toxicity of Antiretroviral Therapy.

Authors:  Luc Bertrand; Martina Velichkovska; Michal Toborek
Journal:  J Neuroimmune Pharmacol       Date:  2019-06-17       Impact factor: 4.147

7.  Methamphetamine and HIV-Tat Protein Synergistically Induce Oxidative Stress and Blood-Brain Barrier Damage via Transient Receptor Potential Melastatin 2 Channel.

Authors:  Jian Huang; Ruilin Zhang; Shangwen Wang; Dongxian Zhang; Chi-Kwan Leung; Genmeng Yang; Yuanyuan Li; Liu Liu; Yue Xu; Shucheng Lin; Chan Wang; Xiaofeng Zeng; Juan Li
Journal:  Front Pharmacol       Date:  2021-03-17       Impact factor: 5.810

8.  The protective effect of gastrodin against the synergistic effect of HIV-Tat protein and METH on the blood-brain barrier via glucose transporter 1 and glucose transporter 3.

Authors:  Juan Li; Jian Huang; Yongwang He; Wenguang Wang; Chi-Kwan Leung; Dongxian Zhang; Ruilin Zhang; Shangwen Wang; Yuanyuan Li; Liu Liu; Xiaofeng Zeng; Zhen Li
Journal:  Toxicol Res (Camb)       Date:  2021-01-22       Impact factor: 3.524

9.  Selective Disruption of the Blood-Brain Barrier by Zika Virus.

Authors:  Ana Rachel Leda; Luc Bertrand; Ibolya Edit Andras; Nazira El-Hage; Madhavan Nair; Michal Toborek
Journal:  Front Microbiol       Date:  2019-09-18       Impact factor: 5.640

10.  Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier.

Authors:  Valérie Lorin; Anne Danckaert; Françoise Porrot; Olivier Schwartz; Philippe V Afonso; Hugo Mouquet
Journal:  mBio       Date:  2020-10-20       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.